How FDA Is Refreshing Its Recall Readiness Guidance

By Greg Levine, Joshua Oyster and Jessica DeLalio (May 29, 2019, 1:12 PM EDT) -- On April 24, 2019, the U.S. Food and Drug Administration released a draft guidance, entitled "Initiation of Voluntary Recalls Under 21 CFR Part 7, Subpart C," to provide additional guidance to industry regarding timely initiation of voluntary recalls of FDA-regulated products. The draft guidance stresses the importance of being "recall ready" and recommends preparations that manufacturers and distributors should take to facilitate timely voluntary recalls....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!